MedNet To Showcase The iMedNet Partner Program At Partnerships in Clinical Trials 2014
MedNet will once again be participating in the Partnerships in Clinical Trials conference.
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, will once again be participating in the Partnerships in Clinical Trials conference. This year's event will be held March 30 – April 2 in Las Vegas, Nevada. Attendees are encouraged to visit MedNet's booth to see iMedNet EDC – an incredibly flexible and user friendly SaaS-based eClinical technology platform – and learn about the iMedNet Partner Program, created specifically to support the success of Clinical Research Organizations (CROs) and other healthcare consultants.
Key benefits of the iMedNet Partner Program include:
- Predictable and Affordable Pricing
- Plus special partners-only discounts
- Full Sales and Marketing Support
- From sales training to prospective customer referrals
- iMedNet Advisory Forum Membership
- Ensuring partners' eClinical needs are fully addressed
"This year's Partnerships conference will be an exciting one," noted John M. (Rob) Robertson, President and CEO of MedNet Solutions. "We'll have representatives on site to provide interested individuals with iMedNetdemonstrations as well as more details about our iMedNet Partner Program. Since interest in our technology solutions and wrap-around support programs is growing rapidly, we anticipate a busy, but very productive few days."
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
